Low anti‐<scp>HB</scp>c levels are associated with lower risk of virological relapse after nucleos(t)ide analogue cessation in<scp>HB</scp>e antigen‐negative patients-Reference-Cited by-同舟云学术

Low anti‐HBc levels are associated with lower risk of virological relapse after nucleos(t)ide analogue cessation inHBe antigen‐negative patients

Published:2022-10-05 Issue:12 Volume:42 Page:2674-2682
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver International

Author:

Ohlendorf Valerie¹^ORCID,Wübbolding Maximilian¹²³,Gineste Paul⁴,Höner Zu Siederdissen Christoph¹^ORCID,Bremer Birgit¹,Wedemeyer Heiner¹³^ORCID,Cornberg Markus¹²³^ORCID,Maasoumy Benjamin¹²³^ORCID

Affiliation:

1. Department of Gastroenterology, Hepatology and Endocrinology Hannover Medical School Hannover Germany

2. Centre for Individualized Infection Medicine (CiiM), a joint venture of Helmholtz Centre for Infection Research and Hannover Medical School Hannover Germany

3. German Center for Infection Research (DZIF) Partner‐Site Hannover‐Braunschweig Hannover Germany

4. Abivax Paris France

Funder

Fujirebio Europe

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/liv.15433

Reference42 articles.

1. Resolution of the Modulus versus Adhesion Dilemma in Solid Polymer Electrolytes for Rechargeable Lithium Metal Batteries

2. Infection and Cancer: The Case of Hepatitis B

3. Ten‐year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B virus infection

4. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection

5. Selection of chronic hepatitis B therapy with high barrier to resistance

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reply to the letter “Anti‐HBc level predicting virological relapse after stopping nucleos(t)ide analogue in chronic hepatitis B”;Liver International;2023-03-08

2. Anti‐HBc level predicting virological relapse after stopping nucleos(t)ide analogue in chronic hepatitis B;Liver International;2023-02-17